Letters to the Editor

Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia

Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Haematologica Early view Jun 30, 2022 https://doi.org/10.3324/haematol.2022.281214